Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,565.00
2,387.00
2,528.00
2,716.00
2,488.00
2,154.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,565.00
2,387.00
2,528.00
2,716.00
2,488.00
2,154.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
19.00
25.00
-1.00
-86.00
-11.00
Raw Materials Consumed
1,595.00
1,496.00
1,626.00
1,863.00
1,750.00
1,310.00
Power & Fuel Cost
174.00
156.00
154.00
155.00
128.00
98.00
Employee Cost
129.00
112.00
102.00
92.00
82.00
80.00
Operating Expenses
245.00
218.00
218.00
192.00
180.00
147.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
78.00
67.00
57.00
69.00
68.00
65.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
16.00
13.00
11.00
10.00
8.00
5.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,253.00
2,096.00
2,207.00
2,406.00
2,156.00
1,714.00
Operating Profit (PBDIT) excl Other Income
311.00
290.00
320.00
309.00
332.00
440.00
Other Income
2.00
16.00
4.00
2.00
11.00
4.00
Operating Profit (PBDIT)
314.00
306.00
324.00
311.00
343.00
444.00
Interest
36.00
39.00
37.00
37.00
23.00
26.00
Profit before Depriciation and Tax
277.00
267.00
286.00
274.00
320.00
418.00
Depreciation
66.00
55.00
51.00
50.00
50.00
49.00
Profit Before Taxation & Exceptional Items
210.00
211.00
235.00
224.00
269.00
368.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
210.00
211.00
235.00
224.00
269.00
369.00
Provision for Tax
15.00
43.00
63.00
57.00
64.00
88.00
Profit After Tax
194.00
168.00
171.00
166.00
204.00
280.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,240.00
1,155.00
1,020.00
878.00
753.00
591.00
Profit Available for appropriations
1,435.00
1,323.00
1,191.00
1,045.00
958.00
872.00
Appropriations
1,435.00
1,323.00
1,191.00
1,045.00
958.00
872.00
Equity Dividend (%)
20.00%
10.00%
10.00%
10.00%
10.00%
25.00%
Earnings Per Share
21.36
18.35
18.65
17.97
22.12
30.09
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 7.47% vs -5.60% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 7.43% vs -9.54% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -7.02% vs 3.03% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 15.97% vs -2.04% in Mar 2025
Compare Profit and Loss Results of Aarti Drugs
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,565.00
944.00
1,621.00
171.72%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,565.00
944.00
1,621.00
171.72%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-68.00
68.00
100.00%
Raw Materials Consumed
1,595.00
490.00
1,105.00
225.51%
Power & Fuel Cost
174.00
32.00
142.00
443.75%
Employee Cost
129.00
151.00
-22.00
-14.57%
Operating Expenses
245.00
45.00
200.00
444.44%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
78.00
43.00
35.00
81.40%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
16.00
10.00
6.00
60.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,253.00
792.00
1,461.00
184.47%
Operating Profit (PBDIT) excl Other Income
311.00
151.00
160.00
105.96%
Other Income
2.00
2.00
0.00
0.00%
Operating Profit (PBDIT)
314.00
153.00
161.00
105.23%
Interest
36.00
36.00
0.00
0.00%
Profit before Depriciation and Tax
277.00
117.00
160.00
136.75%
Depreciation
66.00
30.00
36.00
120.00%
Profit Before Taxation & Exceptional Items
210.00
86.00
124.00
144.19%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
210.00
86.00
124.00
144.19%
Provision for Tax
15.00
22.00
-7.00
-31.82%
Profit After Tax
194.00
64.00
130.00
203.12%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,240.00
420.00
820.00
195.24%
Profit Available for appropriations
1,435.00
485.00
950.00
195.88%
Appropriations
1,435.00
485.00
950.00
195.88%
Equity Dividend (%)
20%
10%
10.00
Earnings Per Share
21.36
6.4
14.96
233.75%
Profit And Loss - Net Sales
Net Sales 2,565.31 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.47% vs -5.60% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 311.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.43% vs -9.54% in Mar 2025
Profit And Loss - Interest
Interest 36.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -7.02% vs 3.03% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 194.94 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.97% vs -2.04% in Mar 2025






